History
In 1999, Terumo Corporation merged three of the most established and trusted brands in perfusion products, CAPIOX, Sarns and CDI to create Terumo Cardiovascular Systems. The company inherited a rich history that stretches back to the pioneering years of open–heart surgery.
Since 1999, Terumo Cardiovascular Systems has expanded its cardiac surgery product line to include vascular grafts, endoscopic vessel harvesting, and more. (For more details, click on the datelines below.)
Terumo Corporation, our parent company, spans an even greater time period in medical device development. Its first product, a clinical thermometer, was developed in the early 1920s by a group of Japanese doctors and scientists responding to a shortage of medical equipment in Japan. That company later became Terumo Corporation. It has continued to grow and is now one of the largest suppliers of medical devices in Japan.
Today, in virtually every cardiac surgery center around the world, heart teams choose products made by Terumo Cardiovascular Systems.
Timeline
1921 |
Terumo introduced its first product, a clinical thermometer.
|
1963 |
Sarns Inc. produces its first heart-lung machine, the S2000.
|
1981 |
Cardiovascular Devices Inc. (CDI) was founded.
Terumo introduces the world's first hollow fiber oxygenator.
|
1999 |
Terumo acquires the Sarns and CDI brands from 3M.
Terumo Cardiovascular Systems is founded.
Terumo Cardiovascular Systems introduces X Coating,™ a non-heparin biocompatible coating.
|
2000 |
Terumo Cardiovascular Systems becomes exclusive distributor for the Fresenius Continuous Autotransfusion System for North America.
|
2001 |
Terumo Cardiovascular Systems acquires the LifeStream International Inc., Cannulae Division.
Terumo Cardiovascular Systems enters into exclusive distribution agreement with Pall Corporation for cardiovascular filters.
|
2002 |
CAPIOX® Baby-RX™ Neonatal Oxygenator introduced.
Terumo Cardiovascular Systems introduces Terumo® Advanced Perfusion System 1.
Terumo Corporation acquires Vascutek Ltd., a global leader in artificial vascular grafts. For more information, www.vascutek.com.
|
2003 |
Terumo Corporation forms a wholly owned subsidiary, Terumo Heart, Inc., to develop an implantable left ventricular assist device.
|
2004 |
Terumo Heart Inc. announces first implant of DuraHeart® Left Ventricular Assist System in Europe.
|
2005 |
Terumo Cardiovascular Systems launches the VirtuoSaph™ Endoscopic Vein Harvesting System.
Terumo Corporation becomes #1 in the global perfusion products market with the acquisition of Edwards Lifesciences, Ltd. in Japan.
|
2006 |
Terumo Cardiovascular Systems enters into exclusive distribution agreement to distribute SmartPRep platelet gel therapy in the North American cardiovascular market.
Terumo Corporation acquires Microvention, Inc., developer of endovascular treatments for cerebral aneurysms.
Terumo Cardiovascular Systems introduces TLink™ Data Management System.
Terumo Cardiovascular Systems extends its offering of hollow–fiber oxygenators for use with all patients with the launch of the CAPIOX® RX15 Oxygenator in the US.
|
2007 |
2007 Terumo Heart Inc. receives CE mark for the DuraHeart® Left Ventricular Assist System (LVAS) in Europe.
Terumo Cardiovascular Systems becomes the exclusive distributor of Vascutek® Vascular Grafts in the United States.
|
